发改委会同相关部门制定的《推进药品价格改革的意见》终于出台。改革的核心是最大限度减少政府干预,将药品定价权交还给市场。《意见》提出强化价格、医保、招标采购等政策的衔接,但这并不是将定价权分权给医保或卫生行政机构,也不是下放各地方政府。千万不要认为,医保部门在药价改革中的任务是制定“医保药品支付价”。《意见》在如何强化医保控费作用中提出五个方面的措施,内涵丰富且相 Development and Reform Commission with the relevant departments to develop the “promotion of drug price reform opinions” was finally introduced. The core of the reform is to minimize government intervention and return the drug pricing power to the market. The Opinions put forward the convergence of policies such as strengthening prices, medical insurance and bidding and purchasing. However, this does not mean decentralization of pricing power to medical insurance or public health administrative bodies, nor does it decentralize local governments. Do not think that the Medicare department in the drug price reform task is to develop “Medicare drug payment price.” “Opinions” in how to strengthen the role of health insurance control fee proposed five measures, rich in content and phase